Abstract:Natural products, and their derivatives and mimics, have contributed to the development of important therapeutics to combat diseases such as infections and cancers over the past decades. The value of natural products to modern drug discovery is still considerable. However, its development is hampered by a lack of a mechanistic understanding of their molecular action, as opposed to the emerging molecule-targeted therapeutics that are tailored to a specific protein target(s). Recent advances in the mass spectrometry-based proteomic approaches have the potential to offer unprecedented insights into the molecular action of natural products. Chemical proteomics is established as an invaluable tool for the identification of protein targets of natural products. Small-molecule affinity selection combined with mass spectrometry is a successful strategy to "fish" cellular targets from the entire proteome. Mass spectrometry-based profiling of protein expression is also routinely employed to elucidate molecular pathways involved in the therapeutic and possible toxicological responses upon treatment with natural products. In addition, mass spectrometry is increasingly utilized to probe structural aspects of natural products-protein interactions. Limited proteolysis, photoaffinity labeling, and hydrogen/deuterium exchange in conjunction with mass spectrometry are sensitive and high-throughput strategies that provide low-resolution structural information of non-covalent natural product-protein complexes. In this review, we provide an overview on the applications of mass spectrometry-based techniques in the identification and characterization of natural product-protein interactions, and we describe how these applications might revolutionize natural product-based drug discovery.

Protein target discovery of drug and its reactive intermediate metabolite by using proteomic strategy

Methods to Profile the Macromolecular Targets of Small Compounds.

A Proteomic Landscape of Pharmacologic Perturbations for Functional Relevance

Proteomic methods for drug target discovery

Biochemical Reactions in Metabolite-Protein Interaction

Chemical Proteomics to Identify Molecular Targets of Small Compounds

[Chemical Proteomics and Discovery of Drug Targets].

Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics

Application Of Chemistry-Based Functional Proteomics To Screening For Novel Drug Targets

Chemical Proteomics: Terra Incognita for Novel Drug Target Profiling

Metabolomics‐driven Approaches for Identifying Therapeutic Targets in Drug Discovery

Chemical proteomics accelerates the target discovery of natural products

Target identification of natural and traditional medicines with quantitative chemical proteomics approaches.

Proteomics in Computer-Aided Drug Design

Chemistry-based Functional Proteomics for Drug Target Deconvolution

Quantitative Proteomics for Drug Toxicity.

Identification and characterization of molecular targets of natural products by mass spectrometry.

Proteomics： a New Approach for Drug Discovery

Recent advances in the quantification of drug metabolizing enzymes and transporters by proteomic approach

Proteomics approach to illustrate drug action mechanisms.

An immuno-chemo-proteomics method for drug target deconvolution